This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Poland
The drug BICAVERA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Calcium chloride
UNII M4I0D6VV5M - CALCIUM CHLORIDE
|
|
Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat. |
|
2
Glucose monohydrate
UNII LX22YL083G - DEXTROSE MONOHYDRATE
|
|
Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body. |
|
3
Magnesium chloride
UNII 02F3473H9O - MAGNESIUM CHLORIDE
|
|
|
|
4
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
|
5
Sodium hydrogen carbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BICAVERA Solution for peritoneal dialysis | Marketing Authorisation Holder | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05DB | Hypertonic solutions | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05D Peritoneal dialytics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1146316, 1146327, 1779509, 1855694, 1855706 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 64754, 64755, 64756, 81963, 81964, 81965 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 062849, 179126, 180171, 185031, 197200, 373708, 374441, 375130, 413919, 418746, 420664, 444276, 447561, 451990, 459089, 522440, 526406, 589414 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61158552, 65919752, 68225352, 69158682 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-442192674, HR-H-642530950, HR-H-784667420 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100339669, 100339675, 100339681 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
